Test of a Preventive Effect of a Deodorant Device Against Respiratory Infections
Launched by TAIKO PHARMACEUTICAL CO., LTD. · Aug 30, 2009
Trial Information
Current as of July 08, 2025
Unknown status
Keywords
ClinConnect Summary
Chlorine dioxide (ClO2), which is used as household deodorant, is a volatile gas that displays very strong oxidative activity. Indeed, the powerful oxidative activity of chlorine dioxide (Ogata, N., Biochemistry 46, 4898-4911, 2007) is responsible for its antimicrobial activity against bacteria (Benarde, M. A., et al. Appl. Mircrobiol. 15, 257-265, 1967), fungi (Morino, H., et al. Yakugaku Zasshi 127, 773-777, 2007) and viruses (Ogata, N. and Shibata, T. J. Gen. Virol. 89, 60-67, 2008). Recently, we found that the rate of absenteeism due to illness in a school was lower in classrooms where ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those who who agrees with the aim of the study
- Exclusion Criteria:
- • Those who do not agree with the aim of the study
About Taiko Pharmaceutical Co., Ltd.
Taiko Pharmaceutical Co., Ltd. is a prominent biopharmaceutical company dedicated to the research, development, and commercialization of innovative therapies. With a strong focus on addressing unmet medical needs, Taiko leverages cutting-edge science and technology to advance its pipeline, particularly in the fields of oncology and rare diseases. Committed to high standards of quality and ethical practices, the company collaborates with global partners and regulatory bodies to ensure the successful development of its clinical programs. Through its dedication to improving patient outcomes, Taiko Pharmaceutical aims to make a significant impact on the healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Osaka, , Japan
Patients applied
Trial Officials
Norio Ogata, MD, PhD
Principal Investigator
Taiko Pharmaceutical Co., Ltd.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials